SCND Files S-1/A for Delayed Offering, Signaling Future Capital Raise

TL;DR

**SCND is gearing up for a capital raise, so watch for potential dilution but also growth opportunities in the lab instrument sector.**

AI Summary

SCIENTIFIC INDUSTRIES INC (SCND) filed an S-1/A on July 14, 2025, for a delayed or continuous offering of securities under Rule 415, indicating a potential capital raise. The company, classified under Laboratory Analytical Instruments (SIC 3826), is a non-accelerated filer and a smaller reporting company, suggesting a smaller market capitalization and fewer public reporting requirements. Helena Santos serves as the Chief Executive Officer, overseeing operations from Bohemia, New York. The filing does not disclose specific revenue or net income figures, but its status as a smaller reporting company implies a revenue below $100 million and a public float below $250 million. The amendment delays the effective date, signaling ongoing adjustments to the registration statement before the offering commences. This strategic move allows the company flexibility in timing its capital infusion, potentially to align with market conditions or finalize offering terms. The primary business remains the development and sale of laboratory analytical instruments.

Why It Matters

This S-1/A filing signals SCIENTIFIC INDUSTRIES INC's intent to raise capital, which could impact its financial stability and growth prospects. For investors, it means potential dilution from new shares but also funding for expansion in the competitive laboratory analytical instruments market. Employees might see increased job security or growth opportunities if the capital is deployed effectively. Customers could benefit from enhanced product development and innovation. Competitors like Thermo Fisher Scientific or Danaher Corporation operate on a much larger scale, making SCND's capital raise crucial for maintaining its niche and market relevance.

Risk Assessment

Risk Level: medium — The risk level is medium because while the S-1/A indicates a future capital raise, the specific terms, amount, and potential dilution are not yet disclosed. The company's status as a 'smaller reporting company' and 'non-accelerated filer' suggests inherent risks associated with smaller market capitalization and potentially less liquidity, as defined by SEC rules.

Analyst Insight

Investors should monitor subsequent filings for details on the offering size, pricing, and use of proceeds. Evaluate the potential dilution against the company's growth strategy and market position in laboratory analytical instruments before making any investment decisions.

Financial Highlights

debt To Equity

X.X

revenue

$X

operating Margin

X%

total Assets

$X

total Debt

$X

net Income

$X

eps

$X

gross Margin

X%

cash Position

$X

revenue Growth

+X%

Key Numbers

• 333-288450 — SEC File Number (Identifies the specific registration statement for SCIENTIFIC INDUSTRIES INC.)
• 2025-07-14 — Filing Date (Date the S-1/A amendment was filed with the SEC.)
• 0000087802 — Central Index Key (CIK) (Unique identifier for SCIENTIFIC INDUSTRIES INC with the SEC.)
• 3826 — SIC Code (Primary Standard Industrial Classification for Laboratory Analytical Instruments.)
• 1231 — Fiscal Year End (Indicates SCIENTIFIC INDUSTRIES INC's fiscal year ends on December 31st.)
• 7 — Public Document Count (Number of documents associated with this accession number.)
• 251121905 — Film Number (Internal SEC processing number for the filing.)
• 04-2217279 — IRS Employer Identification No. (Tax identification number for SCIENTIFIC INDUSTRIES INC.)
• 885 Third Avenue New York, New York 10020 — Legal Counsel Address (Address for Reitler Kailas & Rosenblatt LLP.)
• 212-209-3050 — Legal Counsel Phone (Telephone number for Reitler Kailas & Rosenblatt LLP.)

Key Players & Entities

• SCIENTIFIC INDUSTRIES INC (company) — Registrant and issuer of securities
• Helena Santos (person) — Chief Executive Officer of Scientific Industries, Inc.
• John F.F. Watkins, Esq. (person) — Legal counsel from Reitler Kailas & Rosenblatt LLP
• Reitler Kailas & Rosenblatt LLP (company) — Legal firm providing counsel for the filing
• SEC (regulator) — United States Securities and Exchange Commission
• Delaware (regulator) — State of incorporation for Scientific Industries, Inc.
• Rule 415 (regulator) — SEC rule for delayed or continuous offerings
• 3826 (regulator) — Standard Industrial Classification Code for Laboratory Analytical Instruments
• 80 Orville Drive, Suite 102 Bohemia, New York 11716 (company) — Principal executive offices address
• 631-567-4700 (dollar_amount) — Business phone number

FAQ

Risk Factors

• Delayed Offering Effectiveness [medium — regulatory]: The company has filed an S-1/A for a delayed or continuous offering under Rule 415. This filing indicates that the company is delaying the effective date of the registration statement, allowing for ongoing adjustments. This strategic move provides flexibility in timing the capital infusion, potentially to align with market conditions or finalize offering terms.
• Market Conditions for Capital Raise [medium — market]: As a smaller reporting company, Scientific Industries Inc. is seeking to raise capital. The success of this offering will be heavily dependent on prevailing market conditions and investor sentiment towards laboratory analytical instrument companies. The delayed effective date suggests the company is monitoring these conditions.
• Dependence on Laboratory Analytical Instruments [medium — operational]: The company's primary business is the development and sale of laboratory analytical instruments. This specialization means that any downturns or shifts in demand within this specific market segment could significantly impact the company's financial performance and its ability to execute its business plan.

Industry Context

Scientific Industries Inc. operates within the Laboratory Analytical Instruments sector (SIC 3826). This industry is characterized by innovation and demand from research institutions, pharmaceutical companies, and industrial laboratories. Competition can be intense, with established players and emerging companies vying for market share through technological advancements and product differentiation.

Regulatory Implications

As a non-accelerated filer and smaller reporting company, Scientific Industries Inc. benefits from reduced regulatory burdens. However, the S-1/A filing itself subjects the company to SEC oversight and compliance requirements related to public offerings. Any misstatements or omissions in the registration statement could lead to regulatory scrutiny.

What Investors Should Do

1. Monitor SEC Filings for Offering Details
2. Evaluate Company's Position in Laboratory Analytical Instruments Market
3. Assess Financial Health Post-Offering

Key Dates

• 2025-07-14: Filing of S-1/A Amendment — Indicates the company is actively pursuing a capital raise through a delayed or continuous offering, and is making adjustments to its registration statement.

Glossary

S-1/A

An amendment to a registration statement filed with the SEC. It is used to update or correct information previously filed on an S-1 form. (This is the primary document type filed by Scientific Industries Inc., indicating their intent to offer securities to the public.)

Rule 415

A rule that permits companies to register securities for a delayed or continuous offering. This allows for flexibility in timing the sale of securities. (Scientific Industries Inc. is utilizing Rule 415, signaling a strategic approach to their capital raise, allowing them to time the offering based on market conditions.)

Smaller Reporting Company

A company that meets certain criteria regarding public float and annual revenues, allowing for reduced SEC disclosure requirements. (Scientific Industries Inc. is classified as a smaller reporting company, which impacts the level of detail provided in their SEC filings and suggests a smaller market capitalization.)

SIC Code

Standard Industrial Classification code, a four-digit number used to classify industries. (The SIC code 3826 identifies Scientific Industries Inc. as operating in the Laboratory Analytical Instruments sector, providing context for its business operations.)

Year-Over-Year Comparison

This filing is an amendment (S-1/A) to a registration statement, not a comparison to a prior year's financial filing. Therefore, direct year-over-year comparisons of financial metrics like revenue growth or margin changes are not applicable based on this document alone. The primary focus is on the intent to conduct a delayed or continuous offering and the associated regulatory disclosures.

Filing Details

This Form S-1/A (Form S-1/A) was filed with the SEC on July 14, 2025 by Helena Santos regarding SCIENTIFIC INDUSTRIES INC (SCND).

View full filing on EDGAR

View Full Filing

View this S-1/A filing on SEC EDGAR